SANJIV HARPAVAT to Portoenterostomy, Hepatic
This is a "connection" page, showing publications SANJIV HARPAVAT has written about Portoenterostomy, Hepatic.
Connection Strength
1.678
-
Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements. JAMA. 2020 03 24; 323(12):1141-1150.
Score: 0.674
-
The association of human milk intake and outcomes in biliary atresia. J Pediatr Gastroenterol Nutr. 2025 Jan; 80(1):163-173.
Score: 0.232
-
Response to Letter: If Biliary Atresia Is a Disease Starting In Utero: Should We Treat Ongoing Cytomegalovirus. J Pediatr Gastroenterol Nutr. 2020 06; 70(6):e137-e138.
Score: 0.171
-
MMP-7: The Next Best Serum Biomarker for Biliary Atresia? J Pediatr. 2019 05; 208:8-9.
Score: 0.157
-
Factors Influencing Time-to-diagnosis of Biliary Atresia. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):850-856.
Score: 0.149
-
Beyond the Pediatric end-stage liver disease system: solutions for infants with biliary atresia requiring liver transplant. World J Gastroenterol. 2014 Aug 28; 20(32):11062-8.
Score: 0.114
-
Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy. Hepatology. 2023 03 01; 77(3):862-873.
Score: 0.051
-
Operational Definitions for Chronic Liver Disease Manifestations and Recurring Clinical Events in Biliary Atresia. J Pediatr Gastroenterol Nutr. 2021 04 01; 72(4):584-591.
Score: 0.045
-
Biliary Atresia Patients With Successful Kasai Portoenterostomy Can Present With Features of Obliterative Portal Venopathy. J Pediatr Gastroenterol Nutr. 2020 07; 71(1):91-98.
Score: 0.043
-
The Fecal Microbiome in Infants With Biliary Atresia Associates With Bile Flow After Kasai Portoenterostomy. J Pediatr Gastroenterol Nutr. 2020 06; 70(6):789-795.
Score: 0.043